Trial intelligence / Profile preview

Intra-individual comparison of petrolatum vs Oleogel-S10 vehicle for cutaneous wound healing

2020-002358-26Phase 2Completed

Sponsor
Amryt Pharma
Start
Jul 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised trial of Birch bark extract in cutaneous wound (2 arms), sponsored by Amryt Pharma. Primary endpoint: Time to complete cutaneous healing (clinical re-epithelialisation). Started Jul 2020; status: completed.

02

Drugs

Birch bark extract
03

Conditions

cutaneous wound

Beyond the preview

Go deeper on 2020-002358-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2020-002358-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call